NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 172 filers reported holding NOVAVAX INC in Q4 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $476,000 | +110.6% | 258,810 | +53.4% | 0.03% | +244.4% |
| Q2 2018 | $226,000 | +37.8% | 168,710 | +27.1% | 0.01% | +28.6% |
| Q4 2017 | $164,000 | -18.0% | 132,719 | -24.7% | 0.01% | -30.0% |
| Q3 2017 | $200,000 | -45.5% | 176,259 | -44.9% | 0.01% | -47.4% |
| Q2 2017 | $367,000 | -47.2% | 319,800 | -41.2% | 0.02% | -40.6% |
| Q1 2017 | $695,000 | -87.3% | 543,500 | -29.6% | 0.03% | -84.2% |
| Q3 2015 | $5,457,000 | +183.9% | 771,901 | +232.0% | 0.20% | +206.1% |
| Q1 2015 | $1,922,000 | – | 232,480 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
| Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
| Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
| Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
| Bellevue Group AG | 325,000 | $410,000 | 0.08% |
| Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
| Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
| Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
| Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
| Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |